Back to Authors

Belakhoua, Sarra

https://orcid.org/0009-0008-0917-4759

Mayo Clinic

Tunis University

Citations 1

Localized Hypertrophic Neuropathy as a Neoplastic Manifestation of KRAS-Mediated RASopathy
Vizcaíno, M. Adelita , Belzberg, Allan J. , Belakhoua, Sarra , Chen, Liam , Staedtke, Verena , Rodríguez, Fausto J. , Rodriguez, Fausto J , Ahlawat, Shivani

Journal of Neuropathology & Experimental Neurology | May 10, 2020 | Volume: 79 | Issue: 6 | Pages: 647-651

10.1093/jnen/nlaa034 Get It

Abstract Localized hypertrophic neuropathy is a rare Schwann cell proliferation that usually affects single nerves from the extremities, and it is of unclear etiology in its pure form. RASopathies are a defined group of genetic diseases with overlapping clinical features, usually secondary to germline mutations in genes encoding either components or regulators of the RAS/MAPK pathway. Herein, we report an 11-year-old boy presenting with café au lait spots and right leg length discrepancy. A fascicular nerve biopsy of the tibial nerve demonstrated a Schwann cell proliferation with prominent onion-bulb formation, satisfying criteria for localized hypertrophic neuropathy. Molecular genetic analysis demonstrated identical KRAS mutations (c38_40dupGCG) in the peripheral nerve lesion and melanocytes from café au lait spots, but not in blood, supporting a diagnosis of a KRAS-mediated rasopathy with mosaicism. Immunohistochemical staining in the peripheral nerve lesion demonstrated strong pERK staining consistent with downstream MAPK pathway activation. This report suggests that at least a subset of localized hypertrophic neuropathies are bonafide, well-differentiated Schwann cell neoplasms developing through oncogenic RAS signaling, which provides new insights into the controversial entity historically known as localized hypertrophic neuropathy.